CANICHELLA, MARTINA
 Distribuzione geografica
Continente #
NA - Nord America 594
EU - Europa 272
AS - Asia 138
AF - Africa 10
SA - Sud America 2
Totale 1.016
Nazione #
US - Stati Uniti d'America 588
IT - Italia 121
SE - Svezia 78
SG - Singapore 57
CN - Cina 43
IN - India 22
RO - Romania 20
BG - Bulgaria 15
DE - Germania 13
TG - Togo 10
ID - Indonesia 9
FI - Finlandia 6
CA - Canada 5
IE - Irlanda 5
AR - Argentina 2
GB - Regno Unito 2
IL - Israele 2
NL - Olanda 2
PL - Polonia 2
BE - Belgio 1
BT - Bhutan 1
CZ - Repubblica Ceca 1
FR - Francia 1
HK - Hong Kong 1
HU - Ungheria 1
LT - Lituania 1
MX - Messico 1
NO - Norvegia 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
TR - Turchia 1
UA - Ucraina 1
Totale 1.016
Città #
Fairfield 97
Ashburn 59
Chandler 50
Seattle 48
Singapore 43
Woodbridge 37
Rome 28
Cambridge 27
Houston 24
Wilmington 22
Princeton 16
Sofia 15
Beijing 13
Ann Arbor 12
Dearborn 12
Lawrence 11
Millbury 11
Lomé 10
Milan 10
New York 10
Jakarta 9
San Paolo di Civitate 8
San Diego 7
Bremen 6
Andover 5
Dublin 5
Florence 5
Plano 5
Santa Clara 5
Helsinki 4
Ottawa 4
Boardman 3
Boston 3
Buffalo 3
Genoa 3
Sassari 3
Abano Terme 2
Bareggio 2
Bengaluru 2
Bühl 2
Capriva del Friuli 2
Des Moines 2
Freiburg im Breisgau 2
Kunming 2
Norwalk 2
Portland 2
Salerno 2
Tel Aviv 2
Treviso 2
Anzio 1
Augusta 1
Berlin 1
Budapest 1
Buenos Aires 1
Caltanissetta 1
Casale Monferrato 1
Casalnuovo di Napoli 1
Central 1
Chicago 1
Concesio 1
Council Bluffs 1
Dallas 1
Falkenstein 1
Federal 1
Gualtieri 1
Guangzhou 1
Hefei 1
Islamabad 1
Istanbul 1
Jinan 1
Lodz 1
London 1
Los Angeles 1
Lucca 1
Mexico City 1
Nanjing 1
Naples 1
Oslo 1
Phoenix 1
Poggio Renatico 1
Prague 1
Redmond 1
Redwood City 1
Riyadh 1
Romola 1
Shenyang 1
Shenzhen 1
Stockholm 1
Thimphu 1
Toronto 1
Trieste 1
Turin 1
Udine 1
Vaiano Cremasco 1
Totale 704
Nome #
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimale residual disease-oriented GIMEMA LAL1913 106
Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma 100
A case of late isolated ovarian relapse of acute lymphoblastic leukemia after an allogeneic stem cell transplant. 94
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial 81
Current and future therapeutic approaches for the treatment of follicular lymphoma 76
Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors. 74
Long-term response to daratumumab in a patient with advanced immunoglobulin light-chain (AL) amyloidosis with organ damage 65
Nivolumab as a safe and effective treatment in an HIV patient with refractory Hodgkin lymphoma 62
null 61
Response to interferon-free direct antivirals (DAAS) treatment in Hcv-related subcutaneous marginal zone B-cell lymphoma with lipoma-like presentation: report of two cases 61
null 51
null 50
Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemia 38
Dasatinib-blinatumomab for ph-positive acute lymphoblastic leukemia in adults 37
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol 28
Clinical Results According to Age in Patients with Chronic Myeloid Leukemia Receiving Imatinib Frontline: the Younger, the Later, the Worse? 25
The Eutos long-term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials 20
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings 20
Very late relapse in a patient with acute promyelocytic leukemia (APL) rescued with a chemotherapy-free protocol 19
Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse? 11
STEM CELL MOBILIZATION FOR AUTOLOGOUS TRANSPLANT IN HEMATOLOGIC MALIGNANCIES. THREE-YEAR EXPERIENCE AT A SINGLE INSTITUTION 6
Totale 1.085
Categoria #
all - tutte 3.430
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.430


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020197 0 0 0 0 17 28 51 32 33 17 7 12
2020/202156 6 14 4 1 3 0 0 7 8 8 5 0
2021/2022189 2 8 13 5 18 10 1 16 19 22 52 23
2022/2023245 28 47 28 14 22 30 1 29 21 4 14 7
2023/2024165 7 17 3 11 14 42 19 8 0 25 15 4
2024/2025103 4 27 16 56 0 0 0 0 0 0 0 0
Totale 1.085